A Case of Rituximab Therapy in Diffuse Alveolar Hemorrhage of Systemic Lupus Erythematosus Refractory to Steroid Pulse Therapy
Journal of Rheumatic Diseases
;
: 201-204, 2014.
Article
in Korean
| WPRIM
| ID: wpr-190176
ABSTRACT
Rituximab is a chimeric murine-human monoclonal antibody that is directed against the specific B-cell CD20 antigen, which has recently been successfully used in active or refractory systemic lupus erythematosus (SLE) manifestations, such as nephritis, thrombocytopenia, and vasculitis. We report a case of a 25-year-old woman diagnosed with diffuse alveolar hemorrhage of SLE refractory to steroid pulse therapy. The patient was treated successfully with rituximab as a part of the immunosuppressive regimen.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thrombocytopenia
/
Vasculitis
/
B-Lymphocytes
/
Antigens, CD20
/
Rituximab
/
Hemorrhage
/
Lupus Erythematosus, Systemic
/
Nephritis
Limits:
Adult
/
Female
/
Humans
Language:
Korean
Journal:
Journal of Rheumatic Diseases
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS